Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Perrigo meets demand

This article was originally published in The Tan Sheet

Executive Summary

The private labeler increases its manufacturing capacity by 10 percent and its production of OTC tablets by 3 billion a year with the addition of a $25 million, 62,000-square foot facility in Allegan, Mich. The company announces the 18-month construction project Oct. 15, a month after adding a 160,000 square-foot manufacturing facility in its $44 million acquisition of JB Laboratories in nearby Holland, Mich., and a week after acquiring Mexican store-brand manufacturer Laboratorios Diba for $25 million (1"The Tan Sheet" Oct. 13, 2008, p. 3). Spokesman Art Shannon says Perrigo planned the expansion before buying JB and Diba, and it may need more manufacturing capacity. Demand for Perrigo's products "is increasing across the board," he says. "We make 30 billion tablets [annually] and it keeps growing with all the new products that we have. We just need additional manufacturing capacity.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102222

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel